6-acetylaminocaproic acid has been researched along with 1-hexadecyl-2-acetyl-glycero-3-phosphocholine in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bulbena, O; Casanovas, LI; Escolar, G; Galmés, JL; Navarro, C | 1 |
1 other study(ies) available for 6-acetylaminocaproic acid and 1-hexadecyl-2-acetyl-glycero-3-phosphocholine
| Article | Year |
|---|---|
Zinc acexamate reduces gastric damage induced by platelet-activating factor.
Topics: Aminocaproates; Aminocaproic Acid; Animals; Blood Pressure; Gastric Mucosa; Male; Mast Cells; Platelet Activating Factor; Rats; Rats, Inbred Strains; Stomach; Stomach Ulcer | 1989 |